Here’s my Pick of the Week’s News as published by Multiple Sclerosis News Today. MS Patients with Spasticity…
admin
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Articles by admin
Nominations are being sought for individuals and groups for the U.K.’s…
Here’s my Pick of the Week’s News as published by Multiple Sclerosis News Today. Sanofi, ImmuNext Partner…
It’s often said of the 2.5 million of people in the world who have multiple…
Here’s my Pick of the Week’s News, as published by Multiple Sclerosis News Today. Inactivity and Poor…
Phoebe Scopes was the first international patient to receive Hematopoietic Stem Cell Transplantation (HSCT) therapy for multiple sclerosis in…
Here are my Picks of the Week’s News, as published by Multiple Sclerosis News Today. Zinbryta Approved…
Last week, I introduced you to Phoebe Scopes, the very first MS patient from another country to undergo hematopoietic stem…
Here’s my Pick of the Week’s News, as published by Multiple Sclerosis News Today. Imbalances in Brain…
MS Patient’s Pick of the Week’s News: UV light, Parasite Protein, Copper, Stem Cells, Palliative
Here is my Pick of the Week’s news, as published in Multiple Sclerosis News Today. UV Light…
This is my Pick of the Week’s News, as published by Multiple Sclerosis News Today. New Company…
MS Patient’s Pick of the Week’s News: DMTs, Availability, Cannabis, Imaging, Sexual Dysfunction
Here is my Pick of the Week’s News as published by Multiple Sclerosis News Today. Effectiveness and…
Here’s my Pick of the Week’s News, as published by Multiple Sclerosis News Today. Immune System May Harbor…
I have made no secret of my distrust of the side effects from many of the disease-modifying therapies (DMTs)…
Here’s my Pick of the Week’s News published last week in Multiple Sclerosis News Today. Ampyra Helps MS…
HSCT in Moscow, Day by Day
Doesn’t time fly? It seems only yesterday that I was preparing to go to Moscow, yet tomorrow will be three…
This is my Pick of the Week’s News, as published by Multiple Sclerosis News Today. Study of…
MS Patient’s Pick of the Week’s News: Lemtrada, Umbilical Stem Cells, Wheat Proteins and Research
Here is my pick of the week’s news items, as published in Multiple Sclerosis News Today. Lemtrada Seen…
A woman who says her life was made miserable by fatigue caused by multiple sclerosis (MS), claims she is…
MS Patient’s Pick of the Week’s News: Remyelination, Ocrevus, Mushrooms, Heparin, Exercise
Here, I comment on my Pick of the Week’s News, as published in Multiple Sclerosis News Today. Myelin…
Here’s my pick of this week’s news, as published in Multiple Sclerosis News Today. How Tecfidera Works to…
MS Patient’s Pick of the Week’s News: Most Effective, Brain MRIs, Vit D3, Lipoic Acid, Modeling
Here’s my Pick of this Week’s News, as published by Multiple Sclerosis News Today. This week is a rather…
Life can be really strange and not always fathomable to someone like me who is not blessed with neither medical…
Continuing to live in your own home when you can no longer look after yourself is an ideal many…
Here’s my Pick of the Week’s News as published by Multiple Sclerosis News Today. #ECTRIMS2016 was undoubtedly the star…
A very full day of activities is planned for today at MS Life, inside London’s ExCel exhibition and convention center.
London’s ExCel exhibition and convention center is set for a busy Saturday as ECTRIMS winds down today and MS…
Friday carries on the ECTRIMS congress’s style of so much going on that it must be difficult for…
Another full day, today, at London’s ExCel center and numerous sessions, presentations, and debates to attract the attention of delegates attending…
Europe’s annual congress discussing treatment, including Patient Empowerment, and research in multiple sclerosis is now underway in London. The 32nd congress…